EGFR MUTATION
Clinical trials for EGFR MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR MUTATION trials appear
Sign up with your email to follow new studies for EGFR MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets tough lung cancers in early trial
Disease control OngoingThis study tests an experimental drug, BAY 2927088, in people with advanced non-small cell lung cancer that has specific changes in the EGFR or HER2 genes. The drug aims to block these abnormal proteins to stop cancer growth. The trial will first find the safest dose and then che…
Matched conditions: EGFR MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
Scientists dig into genetic secrets of Drug-Resistant lung cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers stop responding to targeted therapy (tyrosine kinase inhibitors). Researchers will analyze tumor tissue from 40 patients to find hidden genetic changes that cause drug resistance. The goal is to uncover new ways to treat these resistan…
Matched conditions: EGFR MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC